SCAI

This channel contains news about the Society for Cardiac Angiography and Interventions (SCAI), including coverage of its annual meeting and links to recently released practice guidelines. SCAI is a leading resource in interventional cardiology and cath lab techniques and technologies.

Two versions of the Abiomed Impella percutaneous ventricular assist device being shown at ACC 2018. Impella is the only device currently cleared by the FDA for use in cardiogenic shock.

Feature | Hemodynamic Support Devices | Emmanouil S. Brilakis, M.D., Ph.D., FSCAI and Srihari S. Naidu, M.D., FSCAI

10 Reasons Why it is Time to Learn More About Cardiogenic Shock

Cardiogenic shock (CS) is a low-cardiac-output state resulting in life-threatening end-organ hypoperfusion and hypoxia ...

July 08, 2018

News | Atrial Fibrillation

First Results Reported from AVIATOR 2 Registry for AFib Patients Undergoing PCI

May 15, 2018 – Results of the AVIATOR 2 international registry data show a discrepancy between physician perception and ...

May 15, 2018

News | Peripheral Artery Disease (PAD)

SCAI Releases Consensus Guidelines for Femoral-Popliteal Arterial Interventional Device Selection

May 15, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to ...

May 15, 2018

Sponsored Content

While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the wealth of technological advancements, bringing the necessary tools together in a streamlined workflow has remained a challenge for clinicians

Case Study | Baylor Scott and White Heart Hospital

Contemporary PCI: Utilizing State-of-the-Art Technology to Achieve the Best Outcomes

While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...

May 05, 2023

News | Cath Lab

SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention

May 15, 2018 — Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutan ...

May 15, 2018

Feature | Cath Lab

No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury

May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal ...

May 15, 2018

News | Cath Lab

Culprit Vessel Only Strategy Has Lower Mortality Than Routine Multivessel Intervention

May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used ...

May 15, 2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

Feature | Cardiovascular Clinical Studies

Psoriasis Therapy Can Reduce Coronary Plaque

May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin ...

May 14, 2018

A 3-D printed aortic root with an simulated implant of an Edwards Sapien TAVR valve. New clinical data points to length-of-stay as a new predictor of outcomes in TAVR patients. Image from Henry Ford Hospital.

Feature | Heart Valve Technology

Length of Stay Impacts TAVR Outcomes

May 14, 2018 – A new study finds patients who stay in the hospital for more than 72 hours when undergoing trans-femoral ...

May 14, 2018

The Medtronic Endeavor drug-eluting stent was used in the PERSPECTIVE trial to test its durability in chronic total occlusions (CTOs). #SCAI, #SCAI2018

News | Chronic Total Occlusion (CTO)

Treating CTOs With Zotarolimus-eluting Stents Shows Good Long-term Results

May 14, 2018 – One-year outcomes of patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention ...

May 14, 2018

News | Peripheral Artery Disease (PAD)

SCAI Launches Diagnosis and Treatment Toolkit for Peripheral Artery Disease

May 14, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the SCAI PAD ...

May 14, 2018

PROGRESS-CTO flow chart for the hybrid algorithm. #SCAI, #SCAI2018

News | Chronic Total Occlusion (CTO)

International Registry Shows Good Outcomes in Treating Chronic Total Occlusions (CTOs)

May 14, 2018 — A significant update to the PROGRESS-CTO (PROspective Global Registry for the Study of Chronic Total ...

May 14, 2018

News | Cardiovascular Clinical Studies

Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs

May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients ...

May 14, 2018

Richard Schatz, M.D., (center) is research director of cardiovascular interventions at the Heart, Lung, and Vascular Center at Scripps Clinic, speaking at a SCAI session on collaboration with industry to bring new device technologies to market. He is best known as the co-inventor of the first coronary stent, the Palmaz-Schatz stent. Left is Ziyad Hijazi, M.D., MPH, director of the Sidra Cardiac Program. #SCAI, #SCAI2018

Feature | SCAI

SCAI 2018 Late-breaking Clinical Trials

Here is an aggregation of all the news and late-breaking studies presented at the 2018 Society for Cardiovascular ...

May 14, 2018

News | Heart Valve Technology

First-Ever Risk Tool Helps Predict TAVR Readmission Rates

May 11, 2018 — A new study looked at the effectiveness of a novel risk tool to predict 30-day readmission rates in ...

May 11, 2018

Novel Way to Treat Blood Clots in Lungs, pulmonary embolism, Found Safe and Effective. #SCAI, #SCAI2018

News | Pulmonary Embolism

Novel Way to Treat Blood Clots in Lungs Found Safe and Effective

May 11, 2018 — Results of the FlowTriever Pulmonary Embolectomy (FLARE) study were presented as late-breaking clinical ...

May 11, 2018